ArticleLeukemia2026
Beyond mechanisms: toward patient-centered choices in BTKi-venetoclax fixed-duration therapy for CLL.
Francesca R Mauro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleLeukemia2026
Francesca R Mauro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.